187 related articles for article (PubMed ID: 7474604)
1. [Clinical significance of proliferating cell nuclear antigen (PCNA) and argyrophilic nucleolar organizer region (AgNOR) in testicular tumors].
Ohyama C; Ito A; Tokuyama S; Nakazumi H; Suzuki K; Kawamura S; Sato M; Saito S; Yoshikawa K; Hoshi S
Nihon Hinyokika Gakkai Zasshi; 1995 Oct; 86(10):1543-51. PubMed ID: 7474604
[TBL] [Abstract][Full Text] [Related]
2. [Analysis of proliferating cell nuclear antigen and nucleolar organizer region in testicular tumors].
Kurisu H; Shimabukuro T; Wada T; Yamamoto M; Shameem IA; Otsuka T; Sakano S; Matsuyama H; Naito K; Yamamoto N
Hinyokika Kiyo; 1993 Aug; 39(8):715-20. PubMed ID: 8104387
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of argyrophilic nucleolar organizer region and proliferating cell nuclear antigen in colorectal cancer.
Nakae S; Nakamura T; Ikegawa R; Yoshioka H; Shirono J; Tabuchi Y
J Surg Oncol; 1998 Sep; 69(1):28-35. PubMed ID: 9762888
[TBL] [Abstract][Full Text] [Related]
4. Evaluations of p53 immunoreactivity, nucleolar organizer regions, and proliferating cell nuclear antigen in non-small cell lung carcinoma.
Oyama T; Osaki T; Nose N; Ichiki Y; Inoue M; Imoto H; Yoshimatsu T; Kodate M; Uramoto H; Mizoue T; Yano K; Yasumoto K
Anticancer Res; 2000; 20(1B):505-10. PubMed ID: 10769714
[TBL] [Abstract][Full Text] [Related]
5. Assessment of potential doubling time (Tpot), argyrophilic nucleolar organizer regions (AgNOR), and proliferating cell nuclear antigen (PCNA) as predictors of therapy response in canine non-Hodgkin's lymphoma.
Vail DM; Kisseberth WC; Obradovich JE; Moore FM; London CA; MacEwen EG; Ritter MA
Exp Hematol; 1996 Jun; 24(7):807-15. PubMed ID: 8647231
[TBL] [Abstract][Full Text] [Related]
6. Prognostic value of proliferative activity of ovarian carcinoma as revealed by PCNA and AgNOR analyses.
Ghazizadeh M; Sasaki Y; Araki T; Konishi H; Aihara K
Am J Clin Pathol; 1997 Apr; 107(4):451-8. PubMed ID: 9124214
[TBL] [Abstract][Full Text] [Related]
7. Proliferating cell nuclear antigen and nucleolar organizer regions in CNS tumors: correlation with histological type and tumor grade. A comparative study of 82 cases on paraffin sections.
Korkolopoulou P; Christodoulou P; Papanikolaou A; Thomas-Tsagli E
Am J Surg Pathol; 1993 Sep; 17(9):912-9. PubMed ID: 8102513
[TBL] [Abstract][Full Text] [Related]
8. Nucleolar organizer regions and PCNA expression in prostatic cancers.
Kawase N; Shiokawa A; Ota H; Saitoh T; Yoshida H; Kazama K
Pathol Int; 1994 Mar; 44(3):213-22. PubMed ID: 7517763
[TBL] [Abstract][Full Text] [Related]
9. The prognostic significance of the cytophotometric DNA content and its relationship with the argyrophilic nucleolar organizer regions (AgNOR) and proliferating cell nuclear antigen (PCNA) in oesophageal cancer.
Kuwano H; Sumiyoshi K; Nozoe T; Yasuda M; Watanabe M; Sugimachi K
Eur J Surg Oncol; 1995 Aug; 21(4):368-73. PubMed ID: 7664900
[TBL] [Abstract][Full Text] [Related]
10. Proliferating cell nuclear antigen and nucleolar organizer region for differential diagnosis of dysplasia and adenocarcinoma in gastric biopsies.
Ozercan IH; Bahçecioglu IH; Ozercan MR; Bozlak N; Dogan C; Yekeler H
Indian J Gastroenterol; 2000; 19(2):57-60. PubMed ID: 10812815
[TBL] [Abstract][Full Text] [Related]
11. Assessment of proliferative activity by AgNOR and PCNA in prostatic tissues of ram lambs implanted with zeranol.
Gulbahar MY; Yuksel H; Guvenc T; Okut H
Reprod Domest Anim; 2005 Oct; 40(5):468-74. PubMed ID: 16149954
[TBL] [Abstract][Full Text] [Related]
12. Assessment of proliferative activity in Wilms' tumour.
Delahunt B; Farrant GJ; Bethwaite PB; Nacey JN; Lewis ME
Anal Cell Pathol; 1994 Aug; 7(2):127-38. PubMed ID: 7993823
[TBL] [Abstract][Full Text] [Related]
13. PCNA immunostaining combined with AgNOR staining in esophageal squamous cell carcinoma to identify patients with a poor prognosis.
Morisaki Y; Shima S; Yoshizumi Y; Sugiura Y; Tanaka S; Tamai S
Surg Today; 1995; 25(5):389-95. PubMed ID: 7640465
[TBL] [Abstract][Full Text] [Related]
14. Proliferative activity in oral salivary gland tumors: the role of PCNA and AgNOR assessed by a double staining technique.
Rivero ER; Caliari MV; Tarquínio SB; Loyola AM; de Aguiar MC
J Oral Sci; 2004 Jun; 46(2):87-92. PubMed ID: 15287541
[TBL] [Abstract][Full Text] [Related]
15. Expression of topoisomerase IIalpha, Ki-67, proliferating cell nuclear antigen, p53, and argyrophilic nucleolar organizer regions in vulvar squamous lesions.
Brustmann H; Naudé S
Gynecol Oncol; 2002 Aug; 86(2):192-9. PubMed ID: 12144828
[TBL] [Abstract][Full Text] [Related]
16. The proliferative activity in dysplasia and carcinoma in situ of the uterine cervix analyzed by proliferating cell nuclear antigen immunostaining and silver-binding argyrophilic nucleolar organizer region staining.
Kobayashi I; Matsuo K; Ishibashi Y; Kanda S; Sakai H
Hum Pathol; 1994 Feb; 25(2):198-202. PubMed ID: 7907076
[TBL] [Abstract][Full Text] [Related]
17. Correlation between PCNA expression and AgNOR dots in pituitary adenomas.
Klencki M; Kurnatowska I; Słowińska-Klencka D; Lewiński A; Pawlikowski M
Endocr Pathol; 2001; 12(2):163-9. PubMed ID: 11579682
[TBL] [Abstract][Full Text] [Related]
18. The prognostic importance of the nucleolar organizer region (AgNOR), Ki-67 and proliferating cell nuclear antigen (PCNA) in primary nonurachal bladder adenocarcinoma.
Ozdemir BH; Ozdemir OG; Sertçelik A
APMIS; 2001 Jun; 109(6):428-34. PubMed ID: 11506474
[TBL] [Abstract][Full Text] [Related]
19. An improved system for quantifying AgNOR and PCNA in canine tumors.
Hung LC; Pong VF; Cheng CR; Wong FI; Chu RM
Anticancer Res; 2000; 20(5A):3273-80. PubMed ID: 11062753
[TBL] [Abstract][Full Text] [Related]
20. A comparative assessment of proliferating cell nuclear antigen, c-myc p62, and nucleolar organizer region staining in non-Hodgkin's lymphomas: a histochemical and immunohistochemical study of 200 cases.
Korkolopoulou P; Patsouris E; Pangalis G; Tsenga A; Elemenoglou J; Thomas-Tsangli E; Spandidos D; Kittas C
Hum Pathol; 1993 Apr; 24(4):371-7. PubMed ID: 7684020
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
